<DOC>
	<DOC>NCT01843907</DOC>
	<brief_summary>Randomized Clinical Trial (RCT) To investigate and compare the effect of two preventive interventions on readmission rates, loss of functions, quality of life and cost-benefit.</brief_summary>
	<brief_title>Patient Participation in Prevention of Loss of Functions</brief_title>
	<detailed_description>At baseline: Nutritional status, BMI and weight, depression (GDS5), dementia (MMSE), pain (Verbal Ranking Scale), muscle strength (hand-grip strength, chair-to-stand-test), quality of life (EQ5D), coping (Sense of Coherence 13 item scale), patient experience (NORPEQ), medication management (MedMaide). At follow-up three months after discharge: BMI and weight, depression (GDS5), dementia (MMSE), pain (Verbal Ranking Scale), muscle strength (hand-grip strength, chair-to-stand-test) and EQ5D. In addition, need for initiated municipal assistance after discharge. Project employee who performs data collection is blinded to the group to which the patient is randomized. The control group Patients in the control group undergo the same measurements and registrations at discharge and 3 - month follow-up, as the intervention groups, but receive otherwise usual treatment and care, and are discharged without further intervention. After six months control patients receive a report comprising the screening results, relevant information material and a cover letter. Patients' GP and municipality care section receive a summary of outcomes, as well as a cover letter. Register data Information on mortality, readmissions and services in primary health care are obtained after 6 months from the National Patient Register, Population Register and municipalities.</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<criteria>65 years or older Living in their own home with no contact to the Municipality, both before and after admission Discharged from Department o105 or the Acute Receiving Unit &lt;48 hours from admission. Patients with lifethreatening disease in the terminal stage Patients who does not speak and understand Danish Patients who are not able to communicate and collaborate, with regards to the measurements</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>